Telephone
61.3.8622.5222
Address
Level 2 695 Collins Street Docklands, Victoria (VIC) 3008
Description
Medibank Private Ltd. engages in the underwriting and distribution of private health insurance policies. It operates through the Health Insurance and Medibank Health segments.The Health Insurance segment offers private health insurance products including hospital cover and ancillary cover, as stand-alone products and packaged products. The Medibank Health segment refers to a range of activities including contracting with government and corporate customers to provide health management services, as well as providing a range of telehealth services in Australia. The company was founded in 1976 and is headquartered in Docklands, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 3.53 - 5.31
Trade Value (12mth)
AU$7,182,891.00
1 week
-0.61%
1 month
-6.37%
YTD
27.97%
1 year
29.68%
All time high
5.31
EPS 3 yr Growth
27.10%
EBITDA Margin
0.00%
Operating Cashflow
$514m
Free Cash Flow Return
20.80%
ROIC
20.30%
Interest Coverage
0.00
Quick Ratio
0.00
Shares on Issue (Fully Dilluted)
2754m
HALO Sector
Other Finance
Next Company Report Date
26-Aug-26
Ex Dividend Date (est.)
10-Sep-25
Next Dividend Pay Date (est.)
09-Oct-25
Reporting Currency
AUD
Short Sell (% of issue)
1.16
Date | Announcements |
---|---|
11 September 25 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
10 September 25 |
Change of Director's Interest - David Koczkar
×
Change of Director's Interest - David Koczkar |
10 September 25 |
Notification regarding unquoted securities - MPL
×
Notification regarding unquoted securities - MPL |
05 September 25 |
Medibank Board renewal
×
Medibank Board renewal |
03 September 25 |
Change of Director's Interest - Jay Weatherill
×
Change of Director's Interest - Jay Weatherill |
28 August 25 |
FY25 Results - Appendix 4E and Financial Report
×
FY25 Results - Appendix 4E and Financial Report |
28 August 25 |
FY25 Results - Media Release
×
FY25 Results - Media Release |
28 August 25 |
Dividend/Distribution - MPL
×
Dividend/Distribution - MPL |
28 August 25 |
Medibank final customer give back
×
Medibank final customer give back |
28 August 25 |
FY25 Results - Investor Presentation
×
FY25 Results - Investor Presentation |
04 July 25 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
03 July 25 |
Notification regarding unquoted securities - MPL
×
Notification regarding unquoted securities - MPL |
20 June 25 |
Change in substantial holding
×
Change in substantial holding |
16 May 25 |
FY25 Full Year - Key Dates
×
FY25 Full Year - Key Dates |
16 May 25 |
Change in substantial holding
×
Change in substantial holding |
06 May 25 |
Medibank shares business update and healthcare insights
×
Medibank shares business update and healthcare insights |
04 April 25 |
2022 cybercrime event - consumer class action
×
2022 cybercrime event - consumer class action |
03 April 25 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
25 March 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
27 February 25 |
Medibank to return $160m to customers
×
Medibank to return $160m to customers |
27 February 25 |
HY25 Results - Appendix 4D and Financial Report
×
HY25 Results - Appendix 4D and Financial Report |
27 February 25 |
Dividend/Distribution - MPL
×
Dividend/Distribution - MPL |
27 February 25 |
HY25 Results - Media Release
×
HY25 Results - Media Release |
27 February 25 |
HY25 Results - Investor Presentation
×
HY25 Results - Investor Presentation |
26 February 25 |
Government approves health insurance premium increase
×
Government approves health insurance premium increase |
08 January 25 |
Notification of cessation of securities - MPL
×
Notification of cessation of securities - MPL |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.